Zdrowie i gospodarka · 22/05/2000
FDA Extends Comment Period for Dietary Supplements Containing Ephedrine Alkaloids
The FDA is extending the comment period for a notice regarding new adverse event reports and related information for dietary supplements containing ephedrine alkaloids until July 3, 2000, in response to requests for more time to submit comments.
Source: Federal Register — Food and Drug AdministrationOpen original release →